DOSSIER · UPDATED 18 NOV 2025

IMMvention Therapeutix

IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.

immventionthera.com ↗Claim this profile

Founded: 2017
Headcount: 18
Open roles: 0
Last raised: Debt Financing · $250K

SECTION I · THE BRIEF

Inside IMMvention Therapeutix

Brief #68464Updated 18 NOV 2025DURHAMMEDICAL ORGANIZATIONSDEBT FINANCING

Employbl Dossier

IMMvention Therapeutix

IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.

Founded: 2017
Headcount: 18
Open roles: 0
Last raised: Debt Financing · $250K

Section II · Premium ProfileMembers only

01Engineering interview process at IMMvention TherapeutixLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open IMMvention Therapeutix brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Anil Goyal

Jenny Ting

OPEN ROLES

Hiring at IMMvention Therapeutix

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $9,149,999

IMMvention Therapeutix Funding Rounds

Series Unknown
$2,000,000
Jan 9, 2023
Series Unknown
$2,000,000
Jan 8, 2023
Series Unknown
$6,899,999
Dec 28, 2020
Series Unknown
$6,899,999
Dec 27, 2020
Debt Financing
$250,000
Oct 16, 2019
Debt Financing
$250,000
Oct 15, 2019
Debt Financing Investors
North Carolina Biotechnology Center (NCBiotech)